09:49 AM EST, 11/07/2024 (MT Newswires) -- Lifestance Health Group ( LFST ) shares rose 8.7% in early Thursday trading after the company reported Q3 results that topped analyst estimates and raised its 2024 revenue outlook.

The company reported a Q3 net loss of $0.02 per diluted share, compared with a loss of $0.17 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.07.

Revenue for the quarter ended Sept. 30 was $312.7 million, up from $262.9 million a year earlier.

Analysts surveyed by Capital IQ expected $302.3 million.

The company said it expects Q4 revenue of $302.5 million to $322.5 million. Analysts surveyed by Capital IQ expect $311.3 million.

The company said it now expects 2024 revenue of $1.23 billion to $1.25 billion, compared with $1.20 billion to $1.24 billion previously. Analysts polled by Capital IQ expect $1.23 billion.

Price: 7.75, Change: +0.62, Percent Change: +8.70